Use of Khorana score to predict VTE in patients undergoing chemotherapy for uterine cancer.

Vincent Wagner,Monica Levine,Rachael Piver,Floor Jenniskens Backes,David E. Cohn,Larry J. Copeland,Casey M. Cosgrove,Jeffery Fowler,David M. OMalley,Kristin Bixel

Use of Khorana score to predict VTE in patients undergoing chemotherapy for uterine cancer.

2021

Vincent Wagner
Monica Levine
Rachael Piver
Floor Jenniskens Backes
David E. Cohn
Larry J. Copeland
Casey M. Cosgrove
Jeffery Fowler
David M. OMalley
Kristin Bixel

5589Background: Gynecologic cancers are associated with a high risk of venous thromboembolism (VTE). The Khorana score is a clinically-validated tool to assess risk of VTE in cancer patients (using...

Keywords:

in patient
Internal medicine
Chemotherapy
Cancer
Oncology
Medicine
venous thromboembolism
Uterine cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations